Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives

Table 2

Therapy areas using therapies with pharmacogenomic information in their labels.

Therapy area	Number of
Oncology	54
Psychiatry	27
Infectious diseases	17
Endocrinology	10
Neurology	9
Gastroenterology	9
Cardiology	8
Rheumatology	6
Inborn errors of metabolism	6
Hematology	5
Anesthesiology	4
Pulmonary	4
Urology	2
Dermatology	2
Dental	1
Gynecology	1
Transplantation	1
Toxicology	1

of http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm conducted on July 27, 2016.